ArticlePloS one2014

Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.

Saskia Letz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.